Hiv therapy

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/21 (2006.01) A61P 31/18 (2006.01)

Patent

CA 2299893

The uses of pegylated interferon-alfa, alone, and in association with an anti-HIV-1 drug therapy, and ribavirin for the preparation of a medicament for treating treatment-naive as well as treatment-experienced adult and pediatric patients having HIV-1 infections as well as patients co-infected with HIV-1 and HCV involving comprising a therapeutically effective amount of pegylated interferon-alfa, e.g. , pegylated interferon alfa-2b as monotherapy or preferably in association with a therapeutically effective amount of at least one of ribavirin, IL-2, IL-12, pentafuside alone or in combination with a therapeutically effective amount of an anti-HIV-1 drug therapy, e.g., HAART are disclosed.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Hiv therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hiv therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hiv therapy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1937126

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.